INDIANAPOLIS -- Officials with Roche Diagnostics announced on Monday that it will invest $550 million in its Indianapolis site by 2030.

According to a news release from the company. the site will serve as a hub for the company's manufacturing of continuous glucose monitoring (CGM) systems. Officials said the expansion is expected to create hundreds of jobs.

The release said that CGM technologies offer support for daily diabetes management. The company said that this expansion will help advance science and drive innovation for these products. The company aims to deliver "cutting-edge solutions that improve patient outcomes."

“The challenges of diabetes are pervasive, with millions of Americans living with the constant vigilance and countless daily decisions the disease requires,” Brad Mo

See Full Page